Samsara brings eminent neurologist on board to accelerate ALS/MND treatment development
Longevity Technology,
Professor Dame Pamela Shaw joins Samsara Therapeutics’ scientific advisory board and will expedite its leading candidate’s…
Professor Dame Pamela Shaw joins Samsara Therapeutics’ scientific advisory board and will expedite its leading candidate’s…
Almost 150 years have passed since Jean-Martin Charcot first described amyotrophic lateral sclerosis (ALS), also known as motor…